George Voren
Affiliations: | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
Area:
Neurobiology of AddictionGoogle:
"George Voren"Mean distance: 16.91 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Braunscheidel KM, Voren G, Fowler CD, et al. (2024) SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats. Frontiers in Molecular Neuroscience. 17: 1459098 |
| Grossman YS, Fillinger C, Manganaro A, et al. (2021) Structure and function differences in the prelimbic cortex to basolateral amygdala circuit mediate trait vulnerability in a novel model of acute social defeat stress in male mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Kenny P, Kamenecka T, Voren G, et al. (2018) 11. Orexin-1 Receptor Antagonists as Novel Smoking Cessation Agents Biological Psychiatry. 83: S4-S5 |
| Wall TR, Henderson BJ, Voren G, et al. (2017) TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors. Frontiers in Pharmacology. 8: 641 |
| Muschamp JW, Hollander JA, Thompson JL, et al. (2014) Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences of the United States of America. 111: E1648-55 |
| Kenny PJ, Voren G, Johnson PM. (2013) Dopamine D2 receptors and striatopallidal transmission in addiction and obesity. Current Opinion in Neurobiology. 23: 535-8 |